Strasbourg, France

Nicolas Winssinger

USPTO Granted Patents = 11 


 

Average Co-Inventor Count = 3.8

ph-index = 5

Forward Citations = 103(Granted Patents)


Location History:

  • La Jolla, CA (US) (1999 - 2003)
  • Strasbourg, FR (2007 - 2019)

Company Filing History:


Years Active: 1999-2019

Loading Chart...
Loading Chart...
Loading Chart...
11 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Nicolas Winssinger

Introduction

Nicolas Winssinger is a prominent inventor based in Strasbourg, France. He has made significant contributions to the field of therapeutic agents, holding a total of 11 patents. His work focuses on the synthesis of macrocyclic compounds that have potential applications in treating diseases mediated by kinases and Heat Shock Protein 90 (HSP90).

Latest Patents

One of Winssinger's latest patents involves the synthesis of resorcylic acid lactones, which are useful as therapeutic agents. The patent discloses macrocyclic compounds of various formulae, which are analogs of the pochonin resorcylic acid lactones. These compounds are part of pharmaceutical compositions that can be utilized for the treatment of diseases mediated by kinases and HSP90.

Career Highlights

Throughout his career, Winssinger has worked with esteemed institutions such as Université de Strasbourg and The Scripps Research Institute. His research has led to advancements in the development of therapeutic agents, showcasing his dedication to innovation in the pharmaceutical field.

Collaborations

Winssinger has collaborated with notable scientists, including Sofia Barluenga and Kyriacos Costa Nicolaou. These partnerships have further enriched his research and contributed to the success of his inventions.

Conclusion

Nicolas Winssinger's innovative work in the synthesis of therapeutic agents highlights his significant impact on the field of pharmaceuticals. His contributions continue to pave the way for advancements in medical treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…